What is CBG?
Cannabigerol (CBG) is one of over 100 cannabinoids found in cannabis. It was discovered by Yehiel Gaoni and Raphael Mechoulam in 1964. Unlike delta-9-tetrahydrocannabinol (THC), the main psychoactive compound responsible for cannabis, CBG is a non-intoxicating cannabinoid. This means it does not produce the "highs" typically associated with marijuana use.
The potential therapeutic benefits of CBG
CBG is attracting increasing interest due to its non-psychoactive properties and pharmacological potential. Potential therapeutic benefits of CBG include:
- Antibacterial and antimicrobial properties
- Anti-inflammatory effects
- Neuroprotection and the slowing of neuronal degeneration
- Reducing anxiety and depression
- The treatment of certain skin diseases, such as psoriasis
CBG and the fight against Covid-19
According to a recent study, scientists have discovered that two compounds found in hemp, including CBG, could have a similar effect on preventing severe forms of Covid-19. These compounds would prevent the virus from entering healthy cells, thus limiting infection and the spread of the disease.
The legality and use of CBG
Cannabigerol (CBG), derived from hemp plants, is legal in most countries and authorized for use in cosmetics in Europe. However, it is advisable to check local regulations before using CBG-based products.
CBG is available on the market in various forms, such as:
- CBG Oils and Tinctures
- CBG capsules for oral administration
- Topical CBG creams and lotions
- CBG e-liquids for vaping
CBG vs. CBD: What are the differences?
Cannabidiol (CBD) is another non-psychoactive cannabinoid found in cannabis and widely known for its various therapeutic properties. CBG is often considered the "precursor" or "regulator" of CBD, as it is converted into different cannabinoids, including CBD, during the growth of the cannabis plant.
Although both cannabinoids offer similar therapeutic benefits, there are some differences between CBG and CBD:
- CBG acts directly on the CB1 and CB2 receptors of the endocannabinoid system, while CBD expresses indirect activity, primarily by modulating the function of the CB1 receptor.
- The anti-inflammatory effects of CBG appear to be more potent than those of CBD, particularly for treating inflammatory bowel disorders.
- CBG may also have antibacterial properties superior to those of CBD.
Future potential of CBG in medical research
With its diverse therapeutic properties, CBG is increasingly being studied for its medical potential. New research is continually being conducted to better understand and harness the benefits of CBG on human health, both as a monotherapy and in combination with other cannabinoids.
Overall, it is clear that CBG has a promising impact on health. As research continues, we can expect to discover more therapeutic applications for this natural, non-psychoactive substance. Ultimately, this could help improve the quality of life for many patients and contribute to a healthier future for all
Sources
- https://www.santemagazine.fr/sante/addictions/cannabis/cannabis-pourquoi-il-faut-se-mefier-de-la-skunk-174426
- https://www.lepoint.fr/sante/le-cannabis-un-outil-de-protection-inattendu-contre-le-covid-19–14-01-2022-2460424_40.php
- https://www.newsweed.fr/cannabis/cannabigerol/
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.
